AXS Investments »

West Pharmaceutical Services shares owned by AXS Investments

Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by AXS Investments from 13F filings

Historical chart of AXS Investments investment in West Pharmaceutical Services

Tip: Access up to 7 years of quarterly data

All positions including West Pharmaceutical Services held by AXS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Pharmaceutical Services by AXS Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $75k 213 352.12
2023-09-30 $90k 240 375.21
2023-06-30 $101k 265 382.47
2021-03-31 $482k 1.7k 281.87

More positions owned by AXS Investments

Alphabet Inc-cl A Equity (GOOGL)
Meta Platforms Common (META)
Microsoft Corp Common (MSFT)
Visa Inc-class A Shares Equity (V)
Salesforce Common (CRM)
Mastercard Inc Cl A Common (MA)
Netflix Equity (NFLX)
Accenture Plc-cl A Equity (ACN)
Adobe Common (ADBE)
Servicenow Common (NOW)
Intuit Common (INTU)
Oracle Corp Common (ORCL)
Apple Common (AAPL)
Nvidia Corp Common (NVDA)
Intl Business Machines Corp Common (IBM)

View all positions for AXS Investments

Top funds holding West Pharmaceutical Services

Vanguard Group
Bank of New York Mellon
T. Rowe Price Associates
Franklin Resources
Artisan Partners Limited Partnership
Brown Advisory Holdings Incorporated
Durable Capital Partners
Bamco
Citadel Advisors
Jpmorgan Chase & Co
Norges Bank Investment Management
Massachusetts Financial Services
Alliancebernstein
Legal & General Group
TD Asset Management

View all funds holding West Pharmaceutical Services